OLIMAB 60 MG – 1 PRE-FILLED SYRINGE OF 1 ML

OLIMAB 60 MG contains Denosumab, a monoclonal antibody that works by inhibiting a protein involved in bone breakdown. It is used in treating osteoporosis in postmenopausal women and men who are at an increased risk of fractures. By reducing bone loss and increasing bone density, OLIMAB helps protect against debilitating fractures, especially in the hips and spine.

Usage Instructions:
Administer OLIMAB 60 MG as a subcutaneous injection, typically once every six months.
It is administered by a healthcare professional, usually in the upper arm, upper thigh, or abdomen.
Ensure you are taking sufficient calcium and vitamin D during treatment.
Medicinal Advantages:
Prevents Bone Loss: Significantly reduces bone resorption, helping to maintain bone strength.
Increases Bone Density: Improves bone density in the hips, spine, and other areas prone to fractures.
Fracture Risk Reduction: Lowers the likelihood of fractures in postmenopausal women and men at high risk.
Mechanism of Action:
OLIMAB 60 MG contains Denosumab, which targets and binds to RANKL (a protein necessary for bone resorption). By inhibiting RANKL, it reduces the activity of osteoclasts, the cells responsible for breaking down bone. This results in decreased bone loss and increased bone strength, improving overall bone density and reducing fracture risk.

Off-Label Uses:
In some cases, Denosumab is used off-label for treating bone loss in certain cancer patients, such as those undergoing hormone ablation therapy for prostate or breast cancer.
Expert Advice:
Calcium and Vitamin D: Ensure adequate intake of calcium and vitamin D while on OLIMAB 60 MG to support bone health.
Monitor Bone Density: Regular bone density scans should be performed to monitor progress and adjust treatment if necessary.
Adherence to Injection Schedule: Stick to the bi-annual injection schedule to maintain optimal bone density and fracture prevention.
Precautions:
Low Calcium Levels: Correct any existing low calcium levels before starting treatment with OLIMAB.
Severe Infections: OLIMAB may increase susceptibility to infections; consult a doctor if you experience symptoms of infection.
Jaw Osteonecrosis: Rarely, OLIMAB may cause jawbone problems; regular dental check-ups are recommended.
Storage Conditions:
OLIMAB 60 MG should be stored in a refrigerator at 2°C to 8°C.
Protect from light and do not freeze.
Keep the medication out of the reach of children.
FAQs:
Q1: What is OLIMAB 60 MG used for?
A1: It is used to treat osteoporosis in postmenopausal women and men who are at increased risk of fractures by strengthening bones and reducing bone loss.

Q2: How is OLIMAB 60 MG administered?
A2: It is given as a subcutaneous injection by a healthcare professional once every six months.

Q3: Can OLIMAB be used with other medications?
A3: Consult your healthcare provider before using it with other medications, especially if you’re taking calcium supplements or other treatments for bone health.

Q4: What should I avoid while taking OLIMAB?
A4: Avoid dental procedures like tooth extractions without consulting your doctor, as OLIMAB may increase the risk of jaw problems.

Q5: Are there any side effects?
A5: Common side effects include low calcium levels, back pain, and increased risk of infections. Discuss any unusual symptoms with your doctor.